Boston Partners Long/Short Rsrch Inv holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Boston Partners Long/Short Research Fund Investor Class BPRRX
- NAV / 1-Day Return 13.90 / +0.29 %
- Total Assets 601.8M
-
Adj. Expense Ratio
1.660%
- Expense Ratio 2.170%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Long-Short Equity
- Investment Style Mid Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.97%
- Turnover 65%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:55 AM GMT+0
Morningstar’s Analysis BPRRX
Will BPRRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 10.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Asset Offset | 18.76 | 110M | — |
Cash And Cash Equivalents | 18.55 | 109M | Cash and Equivalents |
Cash Offset | 13.56 | 80M | — |
Flex Ltd | 1.90 | 11M | Technology |
Seagate Technology Holdings PLC | 1.47 | 9M | Technology |
Frontdoor Inc | 1.40 | 8M | Consumer Cyclical |
JPMorgan Chase & Co | 1.27 | 7M | Financial Services |
AbbVie Inc | 1.09 | 6M | Healthcare |
Wells Fargo & Co | 1.09 | 6M | Financial Services |
UnitedHealth Group Inc | 1.03 | 6M | Healthcare |